Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ALTUS PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 48.60 M 138.33 M 85.91 M 30.06 M 128.18 M
    Net Receivables 0.00 3.45 M 0.00 0.00 0.00
    Total Inventories 0.00 0.00 0.00 — —
    Progress Payments & Others 0.00 0.00 0.00 — —
    Prepaid Expenses 954,000.00 1.37 M — — —
    Other Current Assets 2.35 M 2.00 M 2.58 M 2.41 M 0.00
    Current Assets Total 50.95 M 143.79 M 88.49 M 32.47 M 129.14 M
    Long Term Receivables — — — — —
    Investment in Unconsolidated Subsidiaries 0.00 — — — —
    Other Investments 3.70 M 3.70 M — — —
    Property, Plant & Equipment Net 9.60 M 5.99 M 6.72 M 6.76 M 7.59 M
    Property, Plant & Equipment Gross 16.94 M 12.65 M 12.42 M 13.71 M 11.98 M
    Accumulated Depreciation 7.34 M 6.66 M 5.71 M 6.94 M 4.39 M
    Other Assets 0.00 632,000.00 1.25 M 1.35 M 1.65 M
    Deferred Charges — — — — —
    Tangible Other Assets 0.00 25,000.00 393,000.00 1.35 M 1.65 M
    Intangible Other Assets 0.00 607,000.00 861,000.00 — —
    Total Assets 64.25 M 154.11 M 96.46 M 40.58 M 138.37 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 1.31 M 2.14 M 2.11 M 2.27 M 972,000.00
    Accrued Payroll 1.05 M 2.50 M 1.48 M 704,000.00 445,000.00
    Income Taxes Payable — — — — —
    Dividends Payable — — — — —
    Other Current Liabilities 12.48 M 11.99 M 10.98 M 12.04 M 6.80 M
    Current Liabilities Total 16.52 M 19.62 M 17.18 M 18.22 M 10.07 M
    Long Term Debt 1.43 M 738,000.00 2.87 M 3.71 M 4.21 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 —
    Deferred Income 4.23 M 6.67 M 9.25 M — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 9.69 M 7.56 M 701,000.00 0.00 0.00
    Total Liabilities 27.65 M 27.92 M 20.76 M 26.16 M 20.95 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 —
    Minority Interest 0.00 0.00 — — —
    Preferred Stock 6.73 M 6.51 M 6.28 M 5.88 M 5.78 M
    Common Equity 29.87 M 119.69 M 69.42 M 8.55 M 111.64 M
    Common Stock 311,000.00 308,000.00 231,000.00 210,000.00 17,000.00
    Capital Surplus 365.03 M 358.13 M 244.98 M 223.55 M 23.51 M
    Revaluation Reserves — — — — —
    Other Appropriated Reserves 197,000.00 290,000.00 20,000.00 — —
    Unappropriated (Free) Reserves — — — — —
    Retained Earnings -335.67 M -239.05 M -175.81 M -112.12 M -72.05 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees — — — — —
    Unrealized Foreign Exchange Gain (Loss) — — — — —
    Unrealized Gain (Loss) on Marketable Securities — — — — —
    Treasury Stock 0.00 0.00 — — —
    Total Liabilities & Shareholders Equity 64.25 M 154.11 M 96.46 M 40.58 M 138.37 M
    Common Shares Outstanding 31.13 M 30.79 M 23.12 M 20.55 M 9.15 M